194 related articles for article (PubMed ID: 19015397)
1. B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome.
Shanafelt TD; Kay NE; Jenkins G; Call TG; Zent CS; Jelinek DF; Morice WG; Boysen J; Zakko L; Schwager S; Slager SL; Hanson CA
Blood; 2009 Apr; 113(18):4188-96. PubMed ID: 19015397
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification.
Strati P; Shanafelt TD
Blood; 2015 Jul; 126(4):454-62. PubMed ID: 26065657
[TBL] [Abstract][Full Text] [Related]
3. Tumor mutational load is prognostic for progression to therapy among high-count monoclonal B-cell lymphocytosis.
Kleinstern G; Boddicker NJ; O'Brien DR; Allmer C; Rabe KG; Norman AD; Griffin R; Yan H; Ma T; Call TG; Bruins L; Brown S; Bonolo de Campos C; Hanson CA; Leis JF; Ding W; Vachon CM; Kay NE; Oakes CC; Parker AS; Brander DM; Weinberg JB; Furman RR; Shanafelt TD; Cerhan JR; Parikh SA; Braggio E; Slager SL
Blood Adv; 2024 May; 8(9):2118-2129. PubMed ID: 38359367
[TBL] [Abstract][Full Text] [Related]
4. Frequency of monoclonal B-cell lymphocytosis in relatives of patients with chronic lymphocytic leukemia.
Villegas Gracia R; Franco Alzate C; Rendón Henao J; Torres Hernández JD; Jaramillo Arbelaez PE
Colomb Med (Cali); 2016 Jun; 47(2):81-6. PubMed ID: 27546929
[TBL] [Abstract][Full Text] [Related]
5. Natural history of monoclonal B-cell lymphocytosis among relatives in CLL families.
Slager SL; Lanasa MC; Marti GE; Achenbach SJ; Camp NJ; Abbasi F; Kay NE; Vachon CM; Cerhan JR; Johnston JB; Call TG; Rabe KG; Kleinstern G; Boddicker NJ; Norman AD; Parikh SA; Leis JF; Banerji V; Brander DM; Glenn M; Ferrajoli A; Curtin K; Braggio E; Shanafelt TD; McMaster ML; Weinberg JB; Hanson CA; Caporaso NE
Blood; 2021 Apr; 137(15):2046-2056. PubMed ID: 33512457
[TBL] [Abstract][Full Text] [Related]
6. Normal serum protein electrophoresis and mutated IGHV genes detect very slowly evolving chronic lymphocytic leukemia patients.
Chauzeix J; Laforêt MP; Deveza M; Crowther L; Marcellaud E; Derouault P; Lia AS; Boyer F; Bargues N; Olombel G; Jaccard A; Feuillard J; Gachard N; Rizzo D
Cancer Med; 2018 Jun; 7(6):2621-2628. PubMed ID: 29745034
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal B-cell lymphocytosis: a brief review for general clinicians.
Matos DM; Falcão RP
Sao Paulo Med J; 2011 May; 129(3):171-5. PubMed ID: 21755252
[TBL] [Abstract][Full Text] [Related]
8. Prediction of outcomes for high-count monoclonal B lymphocytosis using an epigenetic and immunogenetic signature.
Abdelbaky SB; Giacopelli B; Rabe KG; Yamaguchi K; Wu YZ; Yan H; Shanafelt TD; Parikh SA; Ding W; Hampel PJ; Brown S; Cerhan JR; Vachon CM; Kay NE; Hanson CA; Parker AS; Braggio E; Slager SL; Oakes CC
Blood; 2024 Apr; 143(17):1752-1757. PubMed ID: 38194687
[TBL] [Abstract][Full Text] [Related]
9. High-risk subtypes of chronic lymphocytic leukemia are detectable as early as 16 years prior to diagnosis.
Kolijn PM; Hosnijeh FS; Späth F; Hengeveld PJ; Agathangelidis A; Saleh M; Casabonne D; Benavente Y; Jerkeman M; Agudo A; Barricarte A; Besson C; Sánchez MJ; Chirlaque MD; Masala G; Sacerdote C; Grioni S; Schulze MB; Nieters A; Engelfriet P; Hultdin M; McKay JD; Vermeulen RCH; Langerak AW
Blood; 2022 Mar; 139(10):1557-1563. PubMed ID: 34662377
[TBL] [Abstract][Full Text] [Related]
10. Risk of non-hematologic cancer in individuals with high-count monoclonal B-cell lymphocytosis.
Solomon BM; Chaffee KG; Moreira J; Schwager SM; Cerhan JR; Call TG; Kay NE; Slager SL; Shanafelt TD
Leukemia; 2016 Feb; 30(2):331-6. PubMed ID: 26310541
[TBL] [Abstract][Full Text] [Related]
11. BIRC-3 mutated monoclonal B lymphocytosis without evolution to chronic lymphocytic leukemia (CLL).
Nasr AA; Fund X; Barreau S; Desterke C; Borie C; Oudrhiri N; Faivre J; Bennaceur-Griscelli A; Turhan AG
Leuk Lymphoma; 2024 May; 65(5):692-695. PubMed ID: 38293748
[No Abstract] [Full Text] [Related]
12. LPL is the strongest prognostic factor in a comparative analysis of RNA-based markers in early chronic lymphocytic leukemia.
Kaderi MA; Kanduri M; Buhl AM; Sevov M; Cahill N; Gunnarsson R; Jansson M; Smedby KE; Hjalgrim H; Jurlander J; Juliusson G; Mansouri L; Rosenquist R
Haematologica; 2011 Aug; 96(8):1153-60. PubMed ID: 21508119
[TBL] [Abstract][Full Text] [Related]
13. Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis.
Kleinstern G; Camp NJ; Goldin LR; Vachon CM; Vajdic CM; de Sanjose S; Weinberg JB; Benavente Y; Casabonne D; Liebow M; Nieters A; Hjalgrim H; Melbye M; Glimelius B; Adami HO; Boffetta P; Brennan P; Maynadie M; McKay J; Cocco PL; Shanafelt TD; Call TG; Norman AD; Hanson C; Robinson D; Chaffee KG; Brooks-Wilson AR; Monnereau A; Clavel J; Glenn M; Curtin K; Conde L; Bracci PM; Morton LM; Cozen W; Severson RK; Chanock SJ; Spinelli JJ; Johnston JB; Rothman N; Skibola CF; Leis JF; Kay NE; Smedby KE; Berndt SI; Cerhan JR; Caporaso N; Slager SL
Blood; 2018 Jun; 131(23):2541-2551. PubMed ID: 29674426
[TBL] [Abstract][Full Text] [Related]
14. Lymphocytosis and chronic lymphocytic leukaemia: investigation and management.
Devi A; Thielemans L; Ladikou EE; Nandra TK; Chevassut T
Clin Med (Lond); 2022 May; 22(3):225-229. PubMed ID: 35584829
[TBL] [Abstract][Full Text] [Related]
15. A Case of COVID-19-Induced Lymphocytosis in a Patient With Treatment-Naive CLL: Should It Be treated?
Safarpour D; Srinivasan K; Farooqui M; Roth C; Ghouse M
Clin Lymphoma Myeloma Leuk; 2021 Jan; 21(1):69-72. PubMed ID: 33039356
[No Abstract] [Full Text] [Related]
16. International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia.
Condoluci A; Terzi di Bergamo L; Langerbeins P; Hoechstetter MA; Herling CD; De Paoli L; Delgado J; Rabe KG; Gentile M; Doubek M; Mauro FR; Chiodin G; Mattsson M; Bahlo J; Cutrona G; Kotaskova J; Deambrogi C; Smedby KE; Spina V; Bruscaggin A; Wu W; Moia R; Bianchi E; Gerber B; Zucca E; Gillessen S; Ghielmini M; Cavalli F; Stussi G; Hess MA; Baumann TS; Neri A; Ferrarini M; Rosenquist R; Forconi F; Foà R; Pospisilova S; Morabito F; Stilgenbauer S; Döhner H; Parikh SA; Wierda WG; Montserrat E; Gaidano G; Hallek M; Rossi D
Blood; 2020 May; 135(21):1859-1869. PubMed ID: 32267500
[TBL] [Abstract][Full Text] [Related]
17. Clinical Risks for Chronic Lymphocytic Leukemia.
Brown JR
J Natl Compr Canc Netw; 2024 Apr; 22(3):. PubMed ID: 38626793
[TBL] [Abstract][Full Text] [Related]
18. Clinico-Haematological Profile Of Chronic Lymphoproliferative Disorders In Patients Presenting With Lymphocytosis.
Rashid A; Ali Meerza SS; Mansoori H; Shaikh MS
J Pak Med Assoc; 2023 Sep; 73(9):1816-1820. PubMed ID: 37817690
[TBL] [Abstract][Full Text] [Related]
19. Serologic markers of effective tumor immunity against chronic lymphocytic leukemia include nonmutated B-cell antigens.
Marina O; Hainz U; Biernacki MA; Zhang W; Cai A; Duke-Cohan JS; Liu F; Brusic V; Neuberg D; Kutok JL; Alyea EP; Canning CM; Soiffer RJ; Ritz J; Wu CJ
Cancer Res; 2010 Feb; 70(4):1344-55. PubMed ID: 20124481
[TBL] [Abstract][Full Text] [Related]
20. Prognostication of chronic lymphocytic leukemia in the era of new agents.
Eichhorst B; Hallek M
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):149-155. PubMed ID: 27913474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
